FDA-approved drug shows promise against ALS in mice
The cause of amyotrophic lateral sclerosis (ALS) — a disabling neurodegenerative disease that affects nerve cells in the brain and spinal cord and leads to weakened muscles and early death — is not fully understood, but accumulating evidence suggests that inflammatory processes may play a role in the initiation and progression of the condition. In… Read More »